OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
To proof the therapeutic equivalence of once daily (OD) versus three times daily (TID) dosing
of total 3.0 g mesalazine granules in patients with active ulcerative colitis